Conference Paper
BibTex RIS Cite

Year 2012, , 149 - 154, 06.02.2013

Ömer Evirgen , Vicdan Köksaldı Motor

https://doi.org/10.5835/jecm.omu.29.s3.010

Abstract

References

  • Akdeniz, H., Irmak, H., Demiröz, A. P., 1998. Evaluation of brucellosis cases in Van region of Eastern Anatolia: A-3 year experience. Nagoya Med. J. 42, 101-110.
  • Alışkan, H., 2008. Kültür ve serolojik yöntemlerin insan brusellozu tanısındaki değeri. Mikrobiyol. Bul. 42, 185-195.
  • Aliskan, H., Can, F., Demirbilek, M., Colakoglu, S., Kilic, S. and Arslan, H., 2009. Determining in vitro synergistic activities of tigecycline with several other antibiotics against Brucella melitensis using checkerboard and time-kill assays. J. Chemother. 21, 24-30.
  • Almuneef, M. A., Memish, Z. A., Balkhy, H. H., Alotaibi, B., Algoda, S., Abbas, M. and Alsubaie, S., 2004. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol. Infect. 132, 533-540.
  • Altas, M., Evirgen, O., Arica, V. and Tutanc, M., 2010. Pediatric neurobrucellosis associated with hydrocephalus. J. Pediatr. Neurosci. 5, 144- 146.
  • Aydin, M., Fuat Yapar, A., Savas, L., Reyhan, M., Pourbagher, A., Turunc, T. Y., Ziya Demiroglu, Y., Yologlu, N. A., Aktas, A., 2005. Scinti- graphic findings in osteoarticular brucellosis. Nucl. Med. Commun. 26, 639-647.
  • Aygen, B., Doğanay, M., Sümerkan, B., Yildiz, O., Kayabas, Ü., 2002. Clinical manifestations, complications and treatment of brucellosis: A retrospective evaluation of 480 patients. Med. Mal. Infect. 32, 485-493.
  • Bannatyne, R. M., Jackson, M. C., Memish, Z., 1997. Rapid diagnosis of Brucella bacteremia by using the BACTEC 9240 system. J. Clin. Microbiol. 35, 2673-2674.
  • Bayram, Y., Korkoca, H., Aypak, C., Parlak, M., Cikman, A., Kilic, S., Berktas, M., 2011. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens. Int. J. Med. Sci. 8, 198-202.
  • Bodur, H., Erbay, A., Colpan, A., Akinci, E., 2004. Brucellar spondylitis. Rheumatol. Int. 24, 221-226.
  • Buzgan, T., Karahocagil, M. K., Irmak, H., Baran, A. I., Karsen, H., Evirgen, O., Akdeniz, H., 2010. Clinical manifestations and complications in 1028 cases of brucellosis: A retrospective evaluation and review of the literature. Int. J. Infect. Dis. 14, 469-478.
  • Castaneda, M. R., 1947. A practical method for routine blood cultures in brucellosis. Proc. Soc. Exp. Biol. Med. 64, 114.
  • Colmenero, J. D., Reguera, J. M., Martos, F., Sanchez-De-Mora, D., Delgado, M., Causse, M., Martin-Farfan, A., Juarez, C., 1996. Complica- tions associated with Brucella melitensis infection: A study of 530 cases. Medicine (Baltimore). 75, 195-211.
  • Corbel, M. J., 2006. Brucellosis in humans and animals. World Health Organization. Geneva.
  • Dabdoob, W. A., Abdulla, Z. A., 2000. A panel of eight tests in the serodiagnosis and immunological evaluation of acute brucellosis. East. Mediterr. Health J. 6, 304-312.
  • Deepak, S., Bronson, S. G., Sibi, Joseph, W., Thomas, M., 2003. Brucella isolated from bone marrow. J. Assoc. Physicians India. 51, 717-718.
  • Demirel, R., Erdoğan, S., Sözen, M. A., 2009. Determination of high risk regions of human Brucellosis in Turkey using exploratory spatial Analysis. Turkiye Klinikleri J. Med. Sci. 29, 25-35.
  • Dilek, İ., Durmuş, A., Karahocagil, M. K., Akdeniz, H., Karsen, H., Baran, A. İ., Evirgen, Ö., 2008. Hematological complications in 787 cases of acute Brucellosis in Eastern Turkey. Turk. J. Med. Sci. 38, 421-424.
  • Doğanay, M., Meşe, E. A., 2008. Bruselloz. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. A. W. Topçu, G. Söyletir and M. Doğanay. İstanbul, Nobel Tıp Kitabevleri. 1, 897-909.
  • Ertek, M., Yazgı, H., Kadanalı, A., Özden, K., Taşyaran, M. A., 2006. Complications of Brucella infection among adults: An 18-year retrospec- tive evaluation. Turk. J. Med. Sci. 36, 377-381.
  • Evirgen, O., Altas, M., Davran, R., Motor, V. K., Onlen, Y., 2010. Brucellar spondylodiscitis in the cervical region. Pak. J. Med. Sci. 26, 720- 723.
  • Franco, M. P., Mulder, M., Gilman, R. H., Smits, H. L., 2007. Human brucellosis. Lancet Infect. Dis. 7, 775-786.
  • Gotuzzo, E. and Carrillo, C., 2004. Brucella. Infectious Diseases. S. L. Gorbach, J. G. Bartlett and N. R. Blacklow. Philadelphia, Lippincott Williams & Wilkins 1717-1724.
  • Greenfield, R. A., Drevets, D. A., Machado, L. J., Voskuhl, G. W., Cornea, P., Bronze, M. S., 2002. Bacterial pathogens as biological weapons and agents of bioterrorism. Am. J. Med. Sci. 323, 299-315.
  • Gur, A., Geyik, M. F., Dikici, B., Nas, K., Cevik, R., Sarac, J., Hosoglu, S., 2003. Complications of brucellosis in different age groups: A study of 283 cases in southeastern Anatolia of Turkey. Y.M.J. 44, 33-44.
  • Gül, H. C., Coşkun, Ö., Turhan, V., Beşirbellioğlu, B. A., Bilgetürk, A., Erdem, H., Avcı, İ. Y., Görenek, L., Eyigün, C. P., 2007. Bruselloz: 140 Olgunun geriye dönük olarak irdelenmesi. Kor Hek. 6, 249-252.
  • Irmak, H., Buzgan, T., Evirgen, O., Akdeniz, H., Demiroz, A. P., Abdoel, T. H., Smits, H. L., 2004. Use of the Brucella IgM and IgG flow assays in the serodiagnosis of human brucellosis in an area endemic for brucellosis. Am. J. Trop. Med. Hyg. 70, 688-694.
  • Irmak, H., Buzgan, T., Karahocagil, M. K., Evirgen, O., Akdeniz, H., Demiroz, A. P., 2003. The effect of levamisole combined with the classical treatment in chronic brucellosis. Tohoku J. Exp. Med. 201, 221-228.
  • Khan, M. Y., Mah, M.W., Memish, Z. A., 2001. Brucellosis in pregnant women. Clin. Infect. Dis. 32, 1172-1177.
  • Kokoglu, O. F., Hosoglu, S., Geyik, M. F., Ayaz, C., Akalin, S., Buyukbese, M. A., Cetinkaya, A., 2006. Clinical and laboratory features of bru- cellosis in two university hospitals in Southeast Turkey. Trop. Doct. 36, 49-51.
  • Kurdoglu, M., Adali, E., Kurdoglu, Z., Karahocagil, M. K., Kolusari, A., Yildizhan, R., Kucukaydin, Z., Sahin, H. G., Kamaci, M., Akdeniz, H., 2010. Brucellosis in pregnancy: A 6-year clinical analysis. Arch. Gynecol. Obstet. 281, 201-206.
  • La Spada, E., Micalizzi, A., La Spada, M., Quartarano, P., Nugara, G., Soresi, M., Affronti, M., Montalto, G., 2008. [Abnormal liver function in brucellosis]. Infez Med. 16, 148-153.
  • Lapaque, N., Moriyon, I., Moreno, E., Gorvel, J. P., 2005. Brucella lipopolysaccharide acts as a virulence factor. Curr. Opin. Microbiol. 8, 60- 66.
  • Mamıkoğlu, L., 2004. Bruselloz. Gram-Negatif Bakteri İnfeksiyonları. S. Ulusoy, H. Leblebicioğlu, D. Arman. Ankara, Bilimsel Tıp Yayınevi. 327-344.
  • Mantur, B.G., Mangalgi, S.S., 2004. Evaluation of conventional castaneda and lysis centrifugation blood culture techniques for diagnosis of hu- man brucellosis. J. Clin. Microbiol. 42, 4327-4328.
  • Mantur, B. G., Biradar, M. S., Bidri, R. C., Mulimani, M. S., Veerappa, Kariholu, P., Patil, S. B., Mangalgi, S. S., 2006. Protean clinical manifes- tations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area. J. Med. Microbiol. 55, 897-903.
  • Memish, Z. A., Balkhy, H. H., 2004. Brucellosis and international travel. J. Travel Med. 11, 49-55.
  • Memish, Z., Mah, M. W., Al Mahmoud, S., Al Shaalan, M., Khan, M. Y., 2000. Brucella bacteraemia: Clinical and laboratory observations in 160 patients. J. Infectıon. 40, 59-63.
  • Nielsen, K., Smith, P., Widdison, J., Gall, D., Kelly, L., Kelly, W., Nicoletti, P., 2004. Serological relationship between cattle exposed to Brucella abortus, Yersinia enterocolitica O:9 and Escherichia coli O157:H7. Vet. Microbiol. 100, 25-30.
  • Orduna, A., Almaraz, A., Prado, A., Gutierrez, M. P., Garcia-Pascual, A., Duenas, A., Cuervo, M., Abad, R., Hernandez, B., Lorenzo, B., Bratos, M. A., Torres, A. R., 2000. Evaluation of an immunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis. J. Clin. Microbiol. 38, 4000-4005.
  • Örmen, B., Türker, N., Kaptan, F., Ural, S., Vardar, İ., El, S., Yavaş, S., 2004. Brusellozlu 104 olgunun retrospektif değerlendirilmesi İzmir Atatürk Eğitim Hastanesi Tıp Dergisi. 42, 173-176.
  • Pappas, G., Papadimitriou, P., Akritidis, N., Christou, L., Tsianos, E.V., 2006. The new global map of human brucellosis. Lancet Infect. Dis. 6, 91-99.
  • Roushan, M. R., Baiani, M., Javanian, M., Kasaeian, A. A., 2009. Brucellar epididymo-orchitis: Review of 53 cases in Babol, Northern Iran. Scand. J. Infect. Dis. 41, 440-444.
  • Roushan, M. R., Amiri, M. J., Janmohammadi, N., Hadad, M. S., Javanian, M., Baiani, M., Bijani, A., 2010. Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: A randomized clinical trial. J. Antimicrob. Chemoth. 65, 1028-1035.
  • Sayan, M., Kilic, S., Uyanik, M. H., 2012. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey. J. Infect. Chemother. 18, 41-46.
  • Skalsky, K., Yahav, D., Bishara, J., Pitlik, S., Leibovici, L., Paul, M., 2008. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. B.M.J. 336, 701-704.
  • Smits, H. L., Abdoel, T. H., Solera, J., Clavijo, E., Diaz, R., 2003. Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis. Clin. Diagn. Lab. Immunol. 10, 1141-1146.
  • Tasova, Y., Saltoglu, N., Sahin, G., Aksu, H. S., 1999. Osteoarthricular involvement of brucellosis in Turkey. Clin. Rheumatol. 18, 214-219.
  • T.C. Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü, 2006. Çalışma Yıllığı. from http://www.saglik.gov.tr/TR/dosya/1-64856/h/ web2006.rar.
  • Tolomeo, M., Di Carlo, P., Abbadessa, V., Titone, L., Miceli, S., Barbusca, E., Cannizzo, G., Mancuso, S., Arista, S., Scarlata, F., 2003. Monocyte and lymphocyte apoptosis resistance in acute and chronic brucellosis and its possible implications in clinical management. Clin. Infect. Dis. 36, 1533-1538.
  • Turan, H., Serefhanoglu, K., Karadeli, E., Togan, T., Arslan, H., 2011. Osteoarticular involvement among 202 brucellosis cases identified in Central Anatolia region of Turkey. Intern. Med. 50, 421-428.
  • Turunc, T., Demiroglu, Y. Z., Uncu, H., Colakoglu, S., Arslan, H., 2007. A comparative analysis of tuberculous, brucellar and pyogenic spontane- ous spondylodiscitis patients. J. Infectıon. 55, 158-163.
  • Yagupsky, P., 1999. Detection of Brucellae in blood cultures. J. Clin. Microbiol. 37, 3437-3442.
  • Young, E. J., 2010. Brucella species. In Principles and Practice of infectious diseases. G. L. Mandell, J. E. Bennett and R. Dolin. Philadelphia, Churchill Livingstone. 2, 2921-2926.
  • Yüce, A., Alp-Çavuş, S., Yapar, N., Çakır, N., 2006. Bruselloz: 55 olgunun değerlendirilmesi. Klimik Dergisi. 19, 13-17.

Brusellozis

Year 2012, , 149 - 154, 06.02.2013

Ömer Evirgen , Vicdan Köksaldı Motor

https://doi.org/10.5835/jecm.omu.29.s3.010

Abstract

İnsan brusellozu hala dünyanın birçok bölgesinde ve ülkemizde endemik olarak görülmektedir. Ülkemizde özellikle Güneydoğu ve Doğu Anadoludaki bazı illerimizde yoğunluk dikkati çekmektedir. Hastalığın tanısı için kısa sürede sonuç almayı sağlayacak yeni yöntemlere ihtiyaç vardır. Kronik bruselloz ve komplikasyonlarının doğru tanısı, takibi ve tedavisi önemlidir. En önemlisi ise hastalığın insanlara bulaşmasında primer rolü olan süt ve süt ürünlerinin denetimi ve kalite kontrolü ile tüketicilere güvenli ve sağlıklı olarak ulaştırılmasıdır

Keywords

Brusella İnsanlar Hayvanlar Zoonoz Epidemiyoloji Bulaşma Tanı Tedavi

References

  • Akdeniz, H., Irmak, H., Demiröz, A. P., 1998. Evaluation of brucellosis cases in Van region of Eastern Anatolia: A-3 year experience. Nagoya Med. J. 42, 101-110.
  • Alışkan, H., 2008. Kültür ve serolojik yöntemlerin insan brusellozu tanısındaki değeri. Mikrobiyol. Bul. 42, 185-195.
  • Aliskan, H., Can, F., Demirbilek, M., Colakoglu, S., Kilic, S. and Arslan, H., 2009. Determining in vitro synergistic activities of tigecycline with several other antibiotics against Brucella melitensis using checkerboard and time-kill assays. J. Chemother. 21, 24-30.
  • Almuneef, M. A., Memish, Z. A., Balkhy, H. H., Alotaibi, B., Algoda, S., Abbas, M. and Alsubaie, S., 2004. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol. Infect. 132, 533-540.
  • Altas, M., Evirgen, O., Arica, V. and Tutanc, M., 2010. Pediatric neurobrucellosis associated with hydrocephalus. J. Pediatr. Neurosci. 5, 144- 146.
  • Aydin, M., Fuat Yapar, A., Savas, L., Reyhan, M., Pourbagher, A., Turunc, T. Y., Ziya Demiroglu, Y., Yologlu, N. A., Aktas, A., 2005. Scinti- graphic findings in osteoarticular brucellosis. Nucl. Med. Commun. 26, 639-647.
  • Aygen, B., Doğanay, M., Sümerkan, B., Yildiz, O., Kayabas, Ü., 2002. Clinical manifestations, complications and treatment of brucellosis: A retrospective evaluation of 480 patients. Med. Mal. Infect. 32, 485-493.
  • Bannatyne, R. M., Jackson, M. C., Memish, Z., 1997. Rapid diagnosis of Brucella bacteremia by using the BACTEC 9240 system. J. Clin. Microbiol. 35, 2673-2674.
  • Bayram, Y., Korkoca, H., Aypak, C., Parlak, M., Cikman, A., Kilic, S., Berktas, M., 2011. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens. Int. J. Med. Sci. 8, 198-202.
  • Bodur, H., Erbay, A., Colpan, A., Akinci, E., 2004. Brucellar spondylitis. Rheumatol. Int. 24, 221-226.
  • Buzgan, T., Karahocagil, M. K., Irmak, H., Baran, A. I., Karsen, H., Evirgen, O., Akdeniz, H., 2010. Clinical manifestations and complications in 1028 cases of brucellosis: A retrospective evaluation and review of the literature. Int. J. Infect. Dis. 14, 469-478.
  • Castaneda, M. R., 1947. A practical method for routine blood cultures in brucellosis. Proc. Soc. Exp. Biol. Med. 64, 114.
  • Colmenero, J. D., Reguera, J. M., Martos, F., Sanchez-De-Mora, D., Delgado, M., Causse, M., Martin-Farfan, A., Juarez, C., 1996. Complica- tions associated with Brucella melitensis infection: A study of 530 cases. Medicine (Baltimore). 75, 195-211.
  • Corbel, M. J., 2006. Brucellosis in humans and animals. World Health Organization. Geneva.
  • Dabdoob, W. A., Abdulla, Z. A., 2000. A panel of eight tests in the serodiagnosis and immunological evaluation of acute brucellosis. East. Mediterr. Health J. 6, 304-312.
  • Deepak, S., Bronson, S. G., Sibi, Joseph, W., Thomas, M., 2003. Brucella isolated from bone marrow. J. Assoc. Physicians India. 51, 717-718.
  • Demirel, R., Erdoğan, S., Sözen, M. A., 2009. Determination of high risk regions of human Brucellosis in Turkey using exploratory spatial Analysis. Turkiye Klinikleri J. Med. Sci. 29, 25-35.
  • Dilek, İ., Durmuş, A., Karahocagil, M. K., Akdeniz, H., Karsen, H., Baran, A. İ., Evirgen, Ö., 2008. Hematological complications in 787 cases of acute Brucellosis in Eastern Turkey. Turk. J. Med. Sci. 38, 421-424.
  • Doğanay, M., Meşe, E. A., 2008. Bruselloz. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. A. W. Topçu, G. Söyletir and M. Doğanay. İstanbul, Nobel Tıp Kitabevleri. 1, 897-909.
  • Ertek, M., Yazgı, H., Kadanalı, A., Özden, K., Taşyaran, M. A., 2006. Complications of Brucella infection among adults: An 18-year retrospec- tive evaluation. Turk. J. Med. Sci. 36, 377-381.
  • Evirgen, O., Altas, M., Davran, R., Motor, V. K., Onlen, Y., 2010. Brucellar spondylodiscitis in the cervical region. Pak. J. Med. Sci. 26, 720- 723.
  • Franco, M. P., Mulder, M., Gilman, R. H., Smits, H. L., 2007. Human brucellosis. Lancet Infect. Dis. 7, 775-786.
  • Gotuzzo, E. and Carrillo, C., 2004. Brucella. Infectious Diseases. S. L. Gorbach, J. G. Bartlett and N. R. Blacklow. Philadelphia, Lippincott Williams & Wilkins 1717-1724.
  • Greenfield, R. A., Drevets, D. A., Machado, L. J., Voskuhl, G. W., Cornea, P., Bronze, M. S., 2002. Bacterial pathogens as biological weapons and agents of bioterrorism. Am. J. Med. Sci. 323, 299-315.
  • Gur, A., Geyik, M. F., Dikici, B., Nas, K., Cevik, R., Sarac, J., Hosoglu, S., 2003. Complications of brucellosis in different age groups: A study of 283 cases in southeastern Anatolia of Turkey. Y.M.J. 44, 33-44.
  • Gül, H. C., Coşkun, Ö., Turhan, V., Beşirbellioğlu, B. A., Bilgetürk, A., Erdem, H., Avcı, İ. Y., Görenek, L., Eyigün, C. P., 2007. Bruselloz: 140 Olgunun geriye dönük olarak irdelenmesi. Kor Hek. 6, 249-252.
  • Irmak, H., Buzgan, T., Evirgen, O., Akdeniz, H., Demiroz, A. P., Abdoel, T. H., Smits, H. L., 2004. Use of the Brucella IgM and IgG flow assays in the serodiagnosis of human brucellosis in an area endemic for brucellosis. Am. J. Trop. Med. Hyg. 70, 688-694.
  • Irmak, H., Buzgan, T., Karahocagil, M. K., Evirgen, O., Akdeniz, H., Demiroz, A. P., 2003. The effect of levamisole combined with the classical treatment in chronic brucellosis. Tohoku J. Exp. Med. 201, 221-228.
  • Khan, M. Y., Mah, M.W., Memish, Z. A., 2001. Brucellosis in pregnant women. Clin. Infect. Dis. 32, 1172-1177.
  • Kokoglu, O. F., Hosoglu, S., Geyik, M. F., Ayaz, C., Akalin, S., Buyukbese, M. A., Cetinkaya, A., 2006. Clinical and laboratory features of bru- cellosis in two university hospitals in Southeast Turkey. Trop. Doct. 36, 49-51.
  • Kurdoglu, M., Adali, E., Kurdoglu, Z., Karahocagil, M. K., Kolusari, A., Yildizhan, R., Kucukaydin, Z., Sahin, H. G., Kamaci, M., Akdeniz, H., 2010. Brucellosis in pregnancy: A 6-year clinical analysis. Arch. Gynecol. Obstet. 281, 201-206.
  • La Spada, E., Micalizzi, A., La Spada, M., Quartarano, P., Nugara, G., Soresi, M., Affronti, M., Montalto, G., 2008. [Abnormal liver function in brucellosis]. Infez Med. 16, 148-153.
  • Lapaque, N., Moriyon, I., Moreno, E., Gorvel, J. P., 2005. Brucella lipopolysaccharide acts as a virulence factor. Curr. Opin. Microbiol. 8, 60- 66.
  • Mamıkoğlu, L., 2004. Bruselloz. Gram-Negatif Bakteri İnfeksiyonları. S. Ulusoy, H. Leblebicioğlu, D. Arman. Ankara, Bilimsel Tıp Yayınevi. 327-344.
  • Mantur, B.G., Mangalgi, S.S., 2004. Evaluation of conventional castaneda and lysis centrifugation blood culture techniques for diagnosis of hu- man brucellosis. J. Clin. Microbiol. 42, 4327-4328.
  • Mantur, B. G., Biradar, M. S., Bidri, R. C., Mulimani, M. S., Veerappa, Kariholu, P., Patil, S. B., Mangalgi, S. S., 2006. Protean clinical manifes- tations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area. J. Med. Microbiol. 55, 897-903.
  • Memish, Z. A., Balkhy, H. H., 2004. Brucellosis and international travel. J. Travel Med. 11, 49-55.
  • Memish, Z., Mah, M. W., Al Mahmoud, S., Al Shaalan, M., Khan, M. Y., 2000. Brucella bacteraemia: Clinical and laboratory observations in 160 patients. J. Infectıon. 40, 59-63.
  • Nielsen, K., Smith, P., Widdison, J., Gall, D., Kelly, L., Kelly, W., Nicoletti, P., 2004. Serological relationship between cattle exposed to Brucella abortus, Yersinia enterocolitica O:9 and Escherichia coli O157:H7. Vet. Microbiol. 100, 25-30.
  • Orduna, A., Almaraz, A., Prado, A., Gutierrez, M. P., Garcia-Pascual, A., Duenas, A., Cuervo, M., Abad, R., Hernandez, B., Lorenzo, B., Bratos, M. A., Torres, A. R., 2000. Evaluation of an immunocapture-agglutination test (Brucellacapt) for serodiagnosis of human brucellosis. J. Clin. Microbiol. 38, 4000-4005.
  • Örmen, B., Türker, N., Kaptan, F., Ural, S., Vardar, İ., El, S., Yavaş, S., 2004. Brusellozlu 104 olgunun retrospektif değerlendirilmesi İzmir Atatürk Eğitim Hastanesi Tıp Dergisi. 42, 173-176.
  • Pappas, G., Papadimitriou, P., Akritidis, N., Christou, L., Tsianos, E.V., 2006. The new global map of human brucellosis. Lancet Infect. Dis. 6, 91-99.
  • Roushan, M. R., Baiani, M., Javanian, M., Kasaeian, A. A., 2009. Brucellar epididymo-orchitis: Review of 53 cases in Babol, Northern Iran. Scand. J. Infect. Dis. 41, 440-444.
  • Roushan, M. R., Amiri, M. J., Janmohammadi, N., Hadad, M. S., Javanian, M., Baiani, M., Bijani, A., 2010. Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: A randomized clinical trial. J. Antimicrob. Chemoth. 65, 1028-1035.
  • Sayan, M., Kilic, S., Uyanik, M. H., 2012. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey. J. Infect. Chemother. 18, 41-46.
  • Skalsky, K., Yahav, D., Bishara, J., Pitlik, S., Leibovici, L., Paul, M., 2008. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. B.M.J. 336, 701-704.
  • Smits, H. L., Abdoel, T. H., Solera, J., Clavijo, E., Diaz, R., 2003. Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis. Clin. Diagn. Lab. Immunol. 10, 1141-1146.
  • Tasova, Y., Saltoglu, N., Sahin, G., Aksu, H. S., 1999. Osteoarthricular involvement of brucellosis in Turkey. Clin. Rheumatol. 18, 214-219.
  • T.C. Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü, 2006. Çalışma Yıllığı. from http://www.saglik.gov.tr/TR/dosya/1-64856/h/ web2006.rar.
  • Tolomeo, M., Di Carlo, P., Abbadessa, V., Titone, L., Miceli, S., Barbusca, E., Cannizzo, G., Mancuso, S., Arista, S., Scarlata, F., 2003. Monocyte and lymphocyte apoptosis resistance in acute and chronic brucellosis and its possible implications in clinical management. Clin. Infect. Dis. 36, 1533-1538.
  • Turan, H., Serefhanoglu, K., Karadeli, E., Togan, T., Arslan, H., 2011. Osteoarticular involvement among 202 brucellosis cases identified in Central Anatolia region of Turkey. Intern. Med. 50, 421-428.
  • Turunc, T., Demiroglu, Y. Z., Uncu, H., Colakoglu, S., Arslan, H., 2007. A comparative analysis of tuberculous, brucellar and pyogenic spontane- ous spondylodiscitis patients. J. Infectıon. 55, 158-163.
  • Yagupsky, P., 1999. Detection of Brucellae in blood cultures. J. Clin. Microbiol. 37, 3437-3442.
  • Young, E. J., 2010. Brucella species. In Principles and Practice of infectious diseases. G. L. Mandell, J. E. Bennett and R. Dolin. Philadelphia, Churchill Livingstone. 2, 2921-2926.
  • Yüce, A., Alp-Çavuş, S., Yapar, N., Çakır, N., 2006. Bruselloz: 55 olgunun değerlendirilmesi. Klimik Dergisi. 19, 13-17.
There are 55 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Internal Medical Sciences
Authors

Ömer Evirgen

Vicdan Köksaldı Motor

Publication Date February 6, 2013
Submission Date September 30, 2011
Published in Issue Year 2012

Cite

APA Evirgen, Ö., & Köksaldı Motor, V. (2013). Brusellozis. Journal of Experimental and Clinical Medicine, 29(3s), 149-154. https://doi.org/10.5835/jecm.omu.29.s3.010
AMA Evirgen Ö, Köksaldı Motor V. Brusellozis. J. Exp. Clin. Med. February 2013;29(3s):149-154. doi:10.5835/jecm.omu.29.s3.010
Chicago Evirgen, Ömer, and Vicdan Köksaldı Motor. “Brusellozis”. Journal of Experimental and Clinical Medicine 29, no. 3s (February 2013): 149-54. https://doi.org/10.5835/jecm.omu.29.s3.010.
EndNote Evirgen Ö, Köksaldı Motor V (February 1, 2013) Brusellozis. Journal of Experimental and Clinical Medicine 29 3s 149–154.
IEEE Ö. Evirgen and V. Köksaldı Motor, “Brusellozis”, J. Exp. Clin. Med., vol. 29, no. 3s, pp. 149–154, 2013, doi: 10.5835/jecm.omu.29.s3.010.
ISNAD Evirgen, Ömer - Köksaldı Motor, Vicdan. “Brusellozis”. Journal of Experimental and Clinical Medicine 29/3s (February 2013), 149-154. https://doi.org/10.5835/jecm.omu.29.s3.010.
JAMA Evirgen Ö, Köksaldı Motor V. Brusellozis. J. Exp. Clin. Med. 2013;29:149–154.
MLA Evirgen, Ömer and Vicdan Köksaldı Motor. “Brusellozis”. Journal of Experimental and Clinical Medicine, vol. 29, no. 3s, 2013, pp. 149-54, doi:10.5835/jecm.omu.29.s3.010.
Vancouver Evirgen Ö, Köksaldı Motor V. Brusellozis. J. Exp. Clin. Med. 2013;29(3s):149-54.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.